Pharmaceutical

Company News

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for respiratory disorders, including drug-induced respiratory depression and sleep apneas, announced that the Company’s President, CEO and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the Rodman & Renshaw 18th Annual Global Investment Conference (www.rodmanandrenshaw.com) at the Lotte New York Palace Hotel in New York, New York on Monday, September 12, 2016 at 4:15 PM ET.

RespireRx Pharmaceuticals Inc. (OTCQB:RSPI), a leader in the development of medicines for respiratory disorders, including drug-induced respiratory depression and sleep apneas, announced that the Company’s President, CEO and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the Rodman & Renshaw 18th Annual Global Investment Conference (www.rodmanandrenshaw.com) at the Lotte New York Palace Hotel in New York, New York on Monday, September 12, 2016 at 4:15 PM ET. The Conference is sponsored by H.C. Wainwright & Co., LLC and is being held on September 12 and 13, 2016. Dr. Manuso will be available for one-on-one meetings with Conference attendees on both days.
Commented Dr. Manuso, “The presentation at the Rodman & Renshaw Conference will allow us to provide investors with an update on RespireRx’s recent reverse stock split, strategic initiatives and progress on research and development programs. In particular, I look forward to discussing preliminary, top-line results of the Company’s recently concluded Phase 2A clinical trial testing the impact of the Company’s proprietary oral ampakine, CX-1739, on opioid-induced respiratory depression.” Dr. Manuso also will discuss the Company’s other product pipeline candidates, including dronabinol, and the Company’s development timelines. Dr. Manuso concluded, “We are pleased to keep our shareholders and other stakeholders informed as to the continuing progress of RespireRx’s scientific, clinical and regulatory development initiatives.”
Dr. Manuso’s live presentation and accompanying slides will be accessible on Monday, September 12, 2016 at 4:15 PM ET using the following link: http://wsw.com/webcast/rrshq26/rspi. The presentation and slides will be accessible after the presentation by clicking on the investors tab on the RespireRx web-site at www.respirerx.com and following the links and instructions. A copy of the slide presentation being presented at the Conference will be submitted in a Form 8-K filing with the U.S. Securities and Exchange Commission prior to the presentation.

MARKETS

Markets
TSX18861.36-217.28
TSXV617.26-9.08
DOW31097.26+321.83
S&P 5003825.33+39.95
NASD11127.85+99.11
ASX6539.90-28.20

COMMODITIES

Commodities
Gold1810.92+0.89
Silver19.88+0.02
Copper3.61-0.10
Palladium1965.07+9.98
Platinum891.26+2.98
Oil108.46+2.70
Heating Oil3.96+0.13
Natural Gas5.620.00

DOWNLOAD FREE REPORTS

×